AzTrials
AzTrials

Abdominal Aortic AneurysmsRAMiniNCT02888613

Mini-laparotomy Versus Mini Lumbotomy

A study testing mini laparotomy and mini lumbotomy in people with Abdominal Aortic Aneurysms and Abdominal Aortic Thrombosis, run by Central Hospital, Nancy, France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to compare the results of two mini invasive surgical approaches in abdominal aortic surgery: mini lumbotomy with retroperitoneal approach versus mini laparotomy with transperitoneal approach. Respiratory and renal functions and recovery of intestinal transit will be assessed after 30 days. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
mini laparotomy and mini lumbotomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
206 participants
Where
No sites listed yet
Study dates
Sep 2018to Jan 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Elective abdominal aortic repair.
  • Abdominal aneurysm or occlusive aortic disease requiring intervention.
  • Written consent previously provided by the patient.
  • Affiliation to social security.
  • Preliminary medical examination.

Who cannot join

  • Hostile abdomen.
  • Juxta renal abdominal aortic aneurysm.
  • Aneurysmal extension to the iliac arteries.
  • Concomitant visceral arteries lesions.
  • Urgent surgery.
  • Contraindication to surgery.

Trial locations and contacts

No sites are listed yet.

Nicla Settembre, MD, PhD contact

+33(0)383154384

n.settembre@chru-nancy.fr

Sergueï Malikov, MD, PhD contact

+33(0)383153860

s.malikov@chru-nancy.fr

About this study

Official title: Prospective Randomized Study of Two Aortic Surgical Approaches: Mini-laparotomy Versus Mini Lumbotomy

This study aims to compare the results of two mini invasive surgical approaches in abdominal aortic surgery: mini lumbotomy with retroperitoneal approach versus mini laparotomy with transperitoneal approach. Respiratory and renal functions and recovery of intestinal transit will be assessed after 30 days.

The secondary purpose of this study is to assess the life quality and morbi-mortality at 30 days, as well as at 6 and 12 months.

Read the detailed description

Following abdominal aortic surgery, post-operative outcomes are considered favorable with a rapid recovery of respiratory, renal functions and intestinal transit, with limited cardiac events. Complications are still frequent after the classic open abdominal surgery.

In abdominal aortic surgery, "mini" abdominal incision has been proposed as an alternative to the classic large surgical approach.

Two mini surgical approaches are possible: mini lumbotomy with retroperitoneal approach, and mini laparatomy with transperitoneal approach.

Previous studies have only compared classic versus mini surgical approaches and many are retrospectives studies. Pain control through the mini-incision surgery allowed early mobilization of patients, improved lung function, reduced muscle loss, and favoured intestinal motility.

So far, no study has compared the results of two mini invasive aortic approaches.

The aim of this prospective randomized study is to compare two mini-invasive surgical approaches and to determine which of them allows the improvement of surgical outcomes with less morbi-mortality.

Being tested
mini laparotomy, mini lumbotomy
Keywords
mini-lumbotomy, mini-laparotomy, retroperitoneal approach, transperitoneal approach, abdominal aortic surgery
Medical subject headings
Aortic Aneurysm, Abdominal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • mini laparotomyProcedure or surgery

    Also called transperitoneal approach

    The patient will be positioned supine. After induction of general anesthesia, a median umbilical incision will be performed. The average length of the incision of the laparotomy will be 10 cm (8-12 cm). The small intestine will be then mobilized medially and held by an orthostatic retractor. Arterial dissection and control as well as bypasses will be performed according to the conventional technique. In case of occlusive disease of the iliac arteries, femoral site will be selected to achieve the distal anastomoses of the bifurcated prosthetic graft.

  • mini lumbotomyProcedure or surgery

    Also called retro-peritoneal approach

    After induction of general anesthesia, the patient will be positioned in right lateral decubitus at 45° of the table plane. The incision will be performed from the tip of the eleventh rib with a slightly sloping path to the outer edge of the rectus muscle. The average length of the incision of the laparotomy will be 10 cm (8-12 cm).

    Abdominal aorta will be approached retroperitoneally. Arterial dissection and control as well as bypasses will be performed according to the conventional retroperitoneal technique. In case of occlusive disease of the iliac arteries, femoral site will be selected to achieve the distal anastomoses of the bifurcated prosthetic graft.

Study groups in NCT02888613
Study groupRoleWhat they receive
Mini laparotomyOtherPatients with surgical indication to mini invasive aortic repair will be operated after randomisation with transperitoneal approach
Receives: Procedure: mini laparotomy
Mini lumbotomyOtherPatients with surgical indication to mini invasive aortic repair will be operated after randomisation with retroperitoneal approach
Receives: Procedure: mini lumbotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Respiratory recovery

    evaluated with respiratory function test (Sniff nasal inspiratory pressure, SNIP test)

    Measured: day 30

  2. Renal recovery

    evaluated by blood creatinine level, uremia and kalemia

    Measured: day 30

  3. Intestinal transit recovery

    evaluated by reapparition of gas and transit

    Measured: day 30

Secondary outcomes (17)
  1. Respiratory recovery

    evaluated by SNIP test

    Measured: day 1

  2. Respiratory recovery

    evaluated by SNIP test

    Measured: day 3

  3. Respiratory recovery

    evaluated by SNIP test

    Measured: day 5

  4. Renal recovery

    evaluated by creatinine clearance, uremia and kaliemia

    Measured: day 1

  5. Renal recovery

    evaluated by creatinine clearance, uremia and kaliemia

    Measured: day 3

  6. Renal recovery

    evaluated by creatinine clearance, uremia and kaliemia

    Measured: day 5

  7. Intestinal recovery

    assessment of intestinal transit (stool emission)

    Measured: day 1

  8. Intestinal recovery

    assessment of intestinal transit (stool emission)

    Measured: day 3

  9. Intestinal recovery

    assessment of intestinal transit (stool emission)

    Measured: day 5

  10. Post-operative pain assessment

    with VAS scale

    Measured: day 1

  11. Post-operative pain assessment

    with VAS scale

    Measured: day 3

  12. Post-operative pain assessment

    with VAS scale

    Measured: day 5

  13. Quality of life assessment

    by using SF-12 questionnaire

    Measured: after 6 months

  14. Quality of life assessment

    by using SF-12 questionnaire

    Measured: after 1 year

  15. Morbi-mortality

    evaluated by EQ-5D questionnaire

    Measured: after 6 months

  16. Morbi-mortality

    evaluated by EQ-5D questionnaire

    Measured: after 1 year

  17. Morbi-mortality

    evaluated by non-recovery of functions, eventration and death

    Measured: day 30

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Sep 2016 (estimated)
  2. Study startSep 2018 (estimated)
  3. Primary completionJan 2019 (estimated)
  4. Study completionJan 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
206 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02888613
Sponsor's protocol ID
2016-A00990-51
Acronym
RAMini
Status last verified
Sep 2018
First submitted
1 Jul 2016
Last updated
18 Sep 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing mini laparotomy and mini lumbotomy in people with Abdominal Aortic Aneurysms and Abdominal Aortic Thrombosis, run by Central Hospital, Nancy, France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Nicla Settembre, MD, PhD (+33(0)383154384, n.settembre@chru-nancy.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Respiratory recovery (time frame: day 30). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in